Tag: Phase 3 clinical study

November 13, 2019

Clovis Oncology’s Rubraca Available for Reimbursement in Italy

Rubraca is eligible for reimbursement in various countries in Europe, and Clovis is looking at doing the same in more...
November 4, 2019

CymaBay Therapeutics Reaches Target Enrollment in ENHANCE Phase 3 Study

The study is evaluating its seladelpar in patients with primary biliary cholangitis with enrollment to be completed by end of...
August 20, 2019

Myovant Sciences Finishes Patient Recruitment for Phase 3 Trial

Myovant Sciences (NYSE:MYOV) has announced it has finished enrolling patients in its SPIRIT 2 study, which is the first of...
March 6, 2019

Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy

Marinus Pharmaceuticals (NASDAQ:MRNS) has announced it is initiating a Phase 3 clinical study evaluating oral ganaxolone in children with PCDH19-related...
August 7, 2018

Bellerophon Halts Phase 3 Trial

Following the announcement on Tuesday, shares of the company dipped in dramatic fashion by nearly 70 percent over a one-day...